US › Healthcare

China Pharma Holdings Inc (CPHI)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$0.71-2.74%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$948,340

Revenue YoY

-7.5%

Net profit

$-1.5M

EPS

$-0.04

Net margin

-153.8%

Key statistics

Market cap

$32.3M

Forward P/E

1.6

P/B

0.86

Book value

$0.89

EPS (TTM)

$-0.42

52-week high

$8.10

52-week low

$0.50

50-day MA

$0.88

200-day MA

$0.87

Beta

1.05

Analyst view

with an average price target of $3.00.

Shareholding

Insiders

89.63%

Institutions

0.47%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for China Pharma Holdings Inc — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-18.